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Abstract 
 
Background 
Primary prevention should be targeted at individuals with high global cardiovascular 
risk, but research is lacking on how best to identify such individuals in the general 
population. Family history is a good proxy measure of global risk and may provide an 
efficient mechanism for identifying high risk individuals. The aim was to test the 
feasibility of using patients with premature cardiovascular disease to recruit family 
members as a means of identifying and screening high-risk individuals.          
Findings 
We recruited family members of 50 patients attending a cardiology clinic for 
premature coronary heart disease (CHD). We compared their cardiovascular risk with 
a general population control group, and determined their perception of their risk and 
current level of screening. 103 (36%) family members attended screening (27 siblings, 
48 adult offspring and 28 partners). Five (5%) had prevalent CHD. A significantly 
higher percentage had an ASSIGN risk score >20% compared with the general 
population (13% versus 2%, p<0.001). Only 37% of family members were aware they 
were at increased risk and only 50% had had their blood pressure and serum 
cholesterol level checked in the previous three years.    
Conclusions 
Patients attending hospital for premature CHD provide a mechanism to contact family 
members and this can identify individuals with a high global risk who are not 
currently screened.  
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Findings  
 
Primary prevention of cardiovascular disease (CVD) is most effective if people are 
selected for intervention on the basis of their overall cardiovascular risk [1]. The 
Scottish Intercollegiate Guidelines Network (SIGN) recommends treatment of anyone 
at more than 20% risk of a cardiovascular event over the subsequent 10 years [1]. In 
Scotland, this is determined using the ASSIGN risk score derived from data on 
individual risk factors: age, sex, socioeconomic status, family history of CVD, 
cigarette smoking, systolic blood pressure, diabetes, and total and HDL cholesterol 
[2]. However, determining which members of the general population have a high 
cardiovascular risk score is problematic. In England, the Department of Health has 
advocated mass screening of the whole population [3], but this is a high cost, low 
yield strategy [4], and some people are not in regular contact with primary care. 
 
Cardiovascular disease tends to aggregate in families as a result of both genetic 
predisposition and clustering of adverse lifestyles. In Scotland, the 28% of individuals 
whose parents die of CVD account for 61% of everyone with a high global 
cardiovascular risk [4]. Therefore, targeting screening at those with a family history of 
CVD offers a cost effective alternative to mass screening [4]. Guidelines already 
advocate screening of people with a family history of CVD [1][5]. General 
Practitioners are expected to record family history, along with other risk factors, and 
screen individuals accordingly, but previous surveys suggest that this strategy has not 
been effective [6]. The aim was to test the feasibility of using patients attending 
hospital for premature coronary heart disease to identify and contact family members 
as a means of targeting screening at high-risk individuals. The objectives were to       
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determine current levels of awareness and screening among family members and their 
uptake of screening.    
 
We recruited 50 consecutive patients attending the cardiology outpatient clinic at 
Monklands Hospital, Scotland, for premature CHD. Premature CHD was defined as 
chronic stable angina plus angiographic confirmation of >50% stenosis in a man less 
than 55 years of age or a woman less than 65 years of age. Patients provided contact 
details of their family members, defined as siblings, offspring over 20 years of age 
and co-habiting partners. Patients were excluded from the study if they had no family 
members 
 
Relatives and partners were then contacted directly to invite them to attend the index 
patient’s hospital for screening. We used structured, nurse-administered 
questionnaires to collect data on demographic information, lifestyle cardiovascular 
risk factors and medical history. Participants were asked whether they considered 
their risk of cardiovascular disease to be the same as the general population or higher 
and whether they had had their blood pressure and cholesterol level checked over the 
previous three years. The research nurse recorded anthropometric measurements and 
resting blood pressure, and took a fasting blood sample. Written feedback on 
cardiovascular risk factors was provided to participants and their general practitioners. 
Approval for the study was granted by the Lanarkshire Medical Research Ethics 
Committee. 
 
The Scottish Health Survey was used to identify a general population comparison 
group. Subjects with a family history of premature cardiovascular disease were 
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excluded from the comparison group [7]. We used the Scottish Health Survey to 
identify and randomly select comparison individuals matched to family members 
(2:1) by age, sex and deprivation quintile. Family members were compared with the 
general population group in terms of both individual risk factors and ASSIGN score. 
Continuous variables were compared using paired t and Wilcoxon signed rank tests  
for parametric and non-parametric data respectively. Categorical data were compared 
using McNemar’s chi-squared and exact tests, and ordinal data were compared using 
conditional logistic regression. Statistical significance was assumed at the 5% level. 
All statistical analyses were performed using SPSS v15.0 software. 
 
The 50 index patients had a median age at diagnosis of 53 years (IQR 49-53), with a 
median 3 year (IQR 1-7) delay between diagnosis and recruitment to the study. Of the 
290 family members listed by patients, 103 (36%) attended for screening; a mean of 2 
family members per patient. The 103 family members comprised 27 (26%) siblings, 
48 (47%) adult offspring and 28 (27%) partners. Participation rates among siblings, 
offspring and partners were 16%, 57% and 76% respectively. The most common 
reason cited for non-participation was living too far from the hospital. Family 
members had a median age of 41 years and 43% were male. Five (5%) already had 
established CHD. Compared to members of the general population with no family 
history, family members were significantly more likely to smoke, be obese, and have 
hypertension and diabetes (Table 1). ASSIGN risk scores were higher in family 
members than the general population (median 5.39 versus 2.68, p<0.001) (Figure 1). 
Twelve (13%) family members had an estimated probability of a major cardiovascular 
event in the next 10 years of at least 20% compared with only 4 (2%) people from the 
general population (p<0.001).  Ninety seven (94%) family members provided 
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information on perceived risk and previous screening. Only 36 (37%) family members 
perceived their risk of developing CHD in the future to be higher than the general 
population. Awareness of increased risk was higher among offspring (48%) than 
siblings (34%), and lowest among partners (19%). Among family members, only 48 
(50%) had had both their blood pressure and cholesterol checked within the past three 
years, and 33 (34%) within the past year.  
 
Our study demonstrated the feasibility of using patients with premature CHD as a 
means by which to identify and contact people with high global risk who are not 
currently screened. Consistent with previous studies, our results demonstrated that the 
first degree relatives and partners of patients with premature CHD had an increased 
prevalence of individual risk factors and a higher overall risk of future coronary 
events. In spite of existing guidelines recommending screening of people with a 
family history, family members demonstrated a low awareness of their increased risk 
and a lack of screening.  
 
Received wisdom suggests that primary prevention should be targeted at individuals 
with a high global cardiovascular risk rather than on the basis of individual risk 
factors [1]. Research has focused on developing risk prediction models and identifying 
clinical and cost effective intervention strategies, such as lipid-lowering therapies. By 
contrast, there has been a paucity of research into how best to identify which members 
of the general population have a high global risk. In the absence of evidence to the 
contrary, policy-makers have promoted mass screening as the preferred strategy [3]. 
However, such a strategy is difficult to deliver in practice and the absolute cost is 
high. Targeting high risk sub-groups of the population such as individuals in deprived 
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communities and those with a family history offers the potential to identify more than 
84% of those at high global risk by screening only 41% of the population [4]. The 
merits of mass screening are questionable since a further 59 people would need be 
screened to identify an additional high risk individual at a cost of £1,358 [4].       
 
Published studies have consistently demonstrated that people with a family history of 
premature CHD have a significantly increased risk of developing CHD, due to a 
combination of shared genetic predisposition and shared lifestyle [8][9][10]. 
Guidelines already exist recommending screening of people with a family history 
[1][5], yet less than half of the family members in our study had had their blood 
pressure and cholesterol measured in the past three years. In the EuroAspire II Survey 
even fewer (11.1% of siblings and 5.6% of offspring) had undergone screening 
specifically “as a result of CHD in their family” [6]. This may be due, in part, to lack 
of awareness that risk can cluster in families. In previous studies, around half of 
people with a parental history of premature CHD were aware they were at increased 
risk [11][12]. In our study the figures were even lower, with only 41% of first degree 
relatives aware of their increased risk. Partners of patients with CHD have also been 
demonstrated to be at increased risk, as a result of shared lifestyle [13]. Despite this 
partners have largely been excluded from research studies and guidelines [1][5], and, 
in our study, less than one-fifth of partners were aware that they were at increased 
risk. 
 
The strengths of our study included recruitment of unselected patients and inclusion 
of partners, as well as first degree relatives. Previous studies have tended to compare 
individual risk factors, whereas our study also compared global risk. Our comparison 
group was matched at an individual level for age, sex and deprivation quintile and was 
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drawn from the same population. They were not recruited as part of the same study 
but the same questions and measurements were administered. A limitation of this 
study, as with previous studies, is the exclusion of fatal index cases of CHD. 
Compared with non-fatal cases, family members of fatal cases may have a different 
risk profile, risk perception and level of motivation.  
 
Our patients were recruited a median of three years after diagnosis, during which time 
some family members may have been screened and treated. Therefore, our results are 
likely to underestimate the level of increased risk among family members at the time 
of diagnosis. The fact that more than half of family members had not been screened 
since diagnosis demonstrates that existing strategies are not effective. We believe that 
the failure of existing guidelines has resulted from a reliance on general practitioners 
recording family history as a risk factor and targeting individuals accordingly. An 
alternative approach is to ask patients presenting with premature CHD to provide 
details of their family members. Compared with screening of the general population, 
recruitment triggered by a diagnosis of CHD in a family member could lead to greater 
motivation to attend screening and modify lifestyle. This approach is routine practice 
for a number of familial cancers. In cardiological practice it is used for familial 
dyslipidaemia but, as yet, not for general cardiovascular screening. 
 
 
In our study, only 36% of invited family members attended. We can only speculate as 
to whether attendees were representative of all family members and, therefore, 
whether the results are generalisable. Recruitment bias could potentially operate in 
either direction with participation being more likely either among those with pre-
existing awareness and concerns, or those hitherto neglected. In our study, recruitment 
 9  
and screening were both based in a single hospital. We did not have ethics committee 
permission to question non-participants as to their reason for non-attendance. 
However, excessive distance from the clinic was commonly volunteered as a reason 
for non-attendance. Extension of the screening service to include multiple sites across 
the country, would probably improve uptake.  
 
Our findings suggest that patients presenting with premature CHD may provide a 
mechanism to identify family members and thereby improve cardiovascular 
screening. This strategy should be evaluated in a larger, multi-centre study.    
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Figure 1. Distribution of global cardiovascular risk among family members and 
general population controls  
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Table 1. Cardiovascular risk factors among family members and general population 
controls.  
 
 
 
 
Family members 
N=103 
 
 
General population 
N=206 
 
 
P value* 
 
 
 
N (%) 
 
N (%) 
 
Smoking status 
   Never  40 (39) 118 (57) <0.001 
   Ex 20 (19) 42 (20)  
   current  43 (42) 46 (22)  
Body composition     
   BMI ≥ 25 76 (75) 121 (59) 0.009 
   WHR >0.8 (F), >0.9 (M) 72 (72) 114 (57) 0.012 
   Waist >88cm (F), >102 cm (M) 46 (46) 55 (28) 0.001 
Hypertension  35 (35) 50 (25) 0.071 
Diabetes  9 (9) 0 (0) <0.001 
Cholesterol:HDL ratio >4.0 52 (51) 64 (31) 0.001 
 
   
Established CHD 5 (5%) 0 (0%) 0.004 
 
   
 Median (IQR)  Median (IQR)  
Number of cigarettes smoked 15 (10, 20) 12 (6, 16) 0.049 
Systolic blood pressure 129 (119, 142) 124 (115, 133) 0.005 
BMI 28 (25, 32) 26 (24, 28) <0.001 
HDL cholesterol 1.2 (1.0, 1.6) 1.5 (1.2, 1.8) <0.001 
Waist (cm) 94.5 (86.1, 104.0) 87.2 (81.2, 97.0) <0.001 
 
   
 Mean (SD) Mean (SD)  
WHR 0.89 (0.09) 0.86 (0.07) <0.001 
Total cholesterol 5.3 (1.3) 5.4 (1.0) 0.341 
 
   
 
N number, BMI body mass index, WHR waist hip ratio, cm centimetres, F female, M 
male, HDL high density lipoprotein, CHD coronary heart disease  
*paired t test for WHR and total cholesterol, Wilcoxon paired signed rank test for 
remainder of continuous variables, Conditional logistic regression for smoking status, 
McNemar’s exact test for diabetes and established CHD, McNemar’s χ2 test for 
remainder of categorical variables 
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